BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4743100)

  • 1. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
    Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.
    Brumfitt W; Kosmidis J; Hamilton-Miller JM; Gilchrist JN
    Antimicrob Agents Chemother; 1974 Sep; 6(3):290-9. PubMed ID: 15830475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog.
    Knupp CA; Shyu WC; Morgenthien EA; Lee JS; Barbhaiya RH
    Pharm Res; 1993 Aug; 10(8):1157-64. PubMed ID: 8415401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.
    Cretton EM; Zhou Z; Kidd LB; McClure HM; Kaul S; Hitchcock MJ; Sommadossi JP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1816-25. PubMed ID: 8239589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A liner mode of reversible metabolism and its application to bioavailability assessment.
    Hwang S; Kwan KC; Albert KS
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):693-709. PubMed ID: 7341755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa.
    Dobrinska MR; Kukovetz W; Beubler E; Leidy HL; Gomez HJ; Demetriades J; Bolognese JA
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):587-600. PubMed ID: 7182456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the renal clearance of drugs.
    Tucker GT
    Br J Clin Pharmacol; 1981 Dec; 12(6):761-70. PubMed ID: 7041933
    [No Abstract]   [Full Text] [Related]  

  • 9. An integrated approach to the pharmacokinetic analysis of drug absorption.
    Till AE; Benet LZ; Kwan KC
    J Pharmacokinet Biopharm; 1974 Dec; 2(6):525-44. PubMed ID: 4461782
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacokinetics of alpha-methyldopa in dogs.
    Kochak GM; Mason WD
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):405-23. PubMed ID: 3841366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of disopyramide in normal volunteers using unbound concentration.
    Braun J; Sörgel F; Gluth WP; Oie S
    Eur J Clin Pharmacol; 1987; 32(6):625-9. PubMed ID: 3653232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antacids and food on absorption of famotidine.
    Lin JH; Chremos AN; Kanovsky SM; Schwartz S; Yeh KC; Kann J
    Br J Clin Pharmacol; 1987 Oct; 24(4):551-3. PubMed ID: 2891370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.
    Karlsson MO; Bredberg U
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):103-20. PubMed ID: 2348378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.
    Kwan KC; Breault GO; Umbenhauer ER; McMahon FG; Duggan DE
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):255-80. PubMed ID: 978392
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.
    Chiou WL
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):539-46. PubMed ID: 731416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel method for bioavailability assessment.
    Kwan KC; Till AE
    J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
    [No Abstract]   [Full Text] [Related]  

  • 19. Route of administration and drug metabolism.
    Gibaldi M; Feldman S
    Eur J Pharmacol; 1972 Sep; 19(3):323-9. PubMed ID: 4640856
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.